Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice

Identifieur interne : 000627 ( Istex/Corpus ); précédent : 000626; suivant : 000628

Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice

Auteurs : Hideyuki Masaki ; Michael C. Appel ; Linda Leahy ; Jean Leif ; Linda Paquin ; Leonard D. Shultz ; John P. Mordes ; Dale L. Greiner ; Aldo A. Rossini

Source :

RBID : ISTEX:FA45E49EAD425063F681D804106E110FBF006EBC

English descriptors

Abstract

Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA. Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Xenotransplantation 2006; 13: 224–232. © Blackwell Munksgaard, 2006 Abstract:  Background:  The induction of xenogeneic hematopoietic chimerism is an attractive approach for overcoming the host response to xenografts, but establishing xenogeneic chimerism requires severe myeloablative conditioning of the recipient. The goal of this study was to determine if co‐stimulation blockade would facilitate chimerism and xenograft tolerance in irradiation‐conditioned concordant recipients. Methods:  Wistar Furth rat bone marrow (BM) cells were injected into irradiation‐conditioned C57BL/6 mice with or without co‐administration of anti‐mouse CD154 monoclonal antibody (mAb). Chimerism was quantified by flow cytometry, and mice were transplanted with WF rat skin and islet xenografts. Results:  Blockade of CD40–CD154 interaction facilitated establishment of xenogeneic chimerism in mice conditioned with 600 cGy irradiation. Anti‐CD154 mAb was not required for establishment of chimerism in mice treated with 700 cGy. However, mice irradiated with 700 cGy but not treated with anti‐CD154 mAb developed a “graft‐versus‐host disease (GVHD)‐like” wasting syndrome and died, irrespective of their development of chimerism. Xenogeneic chimeras established with irradiation and anti‐CD154 mAb treatment exhibited prolonged skin and, in many cases, permanent islet xenograft survival. Chimerism was unstable and eventually lost in most recipients. Skin xenografts were rejected even in mice that remained chimeric, whereas most islet xenografts survived to the end of the observation period. Conclusions:  Blockade of host CD40–CD154 interaction facilitates the establishment of xenogeneic chimerism and prevents wasting disease and death. Chimerism permits prolonged xenograft survival, but chimerism generated in this way is unstable over time. Skin xenografts are eventually rejected, whereas most islet xenografts survive long term and perhaps permanently.

Url:
DOI: 10.1111/j.1399-3089.2006.00290.x

Links to Exploration step

ISTEX:FA45E49EAD425063F681D804106E110FBF006EBC

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice</title>
<author>
<name sortKey="Masaki, Hideyuki" sort="Masaki, Hideyuki" uniqKey="Masaki H" first="Hideyuki" last="Masaki">Hideyuki Masaki</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Appel, Michael C" sort="Appel, Michael C" uniqKey="Appel M" first="Michael C." last="Appel">Michael C. Appel</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Leahy, Linda" sort="Leahy, Linda" uniqKey="Leahy L" first="Linda" last="Leahy">Linda Leahy</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Leif, Jean" sort="Leif, Jean" uniqKey="Leif J" first="Jean" last="Leif">Jean Leif</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Paquin, Linda" sort="Paquin, Linda" uniqKey="Paquin L" first="Linda" last="Paquin">Linda Paquin</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Shultz, Leonard D" sort="Shultz, Leonard D" uniqKey="Shultz L" first="Leonard D." last="Shultz">Leonard D. Shultz</name>
<affiliation>
<mods:affiliation>The Jackson Laboratory, Bar Harbor, ME, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mordes, John P" sort="Mordes, John P" uniqKey="Mordes J" first="John P." last="Mordes">John P. Mordes</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Greiner, Dale L" sort="Greiner, Dale L" uniqKey="Greiner D" first="Dale L." last="Greiner">Dale L. Greiner</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Rossini, Aldo A" sort="Rossini, Aldo A" uniqKey="Rossini A" first="Aldo A." last="Rossini">Aldo A. Rossini</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FA45E49EAD425063F681D804106E110FBF006EBC</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1111/j.1399-3089.2006.00290.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-MLTTS251-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000627</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000627</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice</title>
<author>
<name sortKey="Masaki, Hideyuki" sort="Masaki, Hideyuki" uniqKey="Masaki H" first="Hideyuki" last="Masaki">Hideyuki Masaki</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Appel, Michael C" sort="Appel, Michael C" uniqKey="Appel M" first="Michael C." last="Appel">Michael C. Appel</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Leahy, Linda" sort="Leahy, Linda" uniqKey="Leahy L" first="Linda" last="Leahy">Linda Leahy</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Leif, Jean" sort="Leif, Jean" uniqKey="Leif J" first="Jean" last="Leif">Jean Leif</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Paquin, Linda" sort="Paquin, Linda" uniqKey="Paquin L" first="Linda" last="Paquin">Linda Paquin</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Shultz, Leonard D" sort="Shultz, Leonard D" uniqKey="Shultz L" first="Leonard D." last="Shultz">Leonard D. Shultz</name>
<affiliation>
<mods:affiliation>The Jackson Laboratory, Bar Harbor, ME, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mordes, John P" sort="Mordes, John P" uniqKey="Mordes J" first="John P." last="Mordes">John P. Mordes</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Greiner, Dale L" sort="Greiner, Dale L" uniqKey="Greiner D" first="Dale L." last="Greiner">Dale L. Greiner</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Rossini, Aldo A" sort="Rossini, Aldo A" uniqKey="Rossini A" first="Aldo A." last="Rossini">Aldo A. Rossini</name>
<affiliation>
<mods:affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Xenotransplantation</title>
<title level="j" type="alt">XENOTRANSPLANTATION</title>
<idno type="ISSN">0908-665X</idno>
<idno type="eISSN">1399-3089</idno>
<imprint>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="224">224</biblScope>
<biblScope unit="page" to="232">232</biblScope>
<biblScope unit="page-count">9</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2006-05">2006-05</date>
</imprint>
<idno type="ISSN">0908-665X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0908-665X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Allogeneic</term>
<term>Allogeneic hematopoietic chimerism</term>
<term>Allograft</term>
<term>Becton dickinson</term>
<term>Bone marrow</term>
<term>Cell injection</term>
<term>Cell transplantation</term>
<term>Central tolerance</term>
<term>Chimera</term>
<term>Chimeric</term>
<term>Chimeric animals</term>
<term>Chimeric mice</term>
<term>Chimerism</term>
<term>Conditioning regimen</term>
<term>Costimulation blockade</term>
<term>Costimulatory blockade</term>
<term>Deletional tolerance</term>
<term>Furth</term>
<term>Graft</term>
<term>Graft survival</term>
<term>Gvhd</term>
<term>Hematopoietic</term>
<term>Hematopoietic chimerism</term>
<term>Host interaction</term>
<term>Immunol</term>
<term>Islet</term>
<term>Islet xenograft survival</term>
<term>Islet xenografts</term>
<term>Long term</term>
<term>Many cases</term>
<term>Monoclonal</term>
<term>Monoclonal antibody</term>
<term>Mouse</term>
<term>Observation period</term>
<term>Pbmc</term>
<term>Peripheral blood</term>
<term>Permanent islet xenograft survival</term>
<term>Plasma glucose concentration</term>
<term>Recipient mice</term>
<term>Regimen</term>
<term>Rt1a</term>
<term>Skin grafts</term>
<term>Skin xenograft survival</term>
<term>Skin xenografts</term>
<term>Syndrome</term>
<term>Transplantation</term>
<term>Transplantation tolerance</term>
<term>Wistar</term>
<term>Wistar furth</term>
<term>Xenogeneic</term>
<term>Xenogeneic chimerism</term>
<term>Xenogeneic hematopoietic chimerism</term>
<term>Xenograft</term>
<term>Xenograft survival</term>
<term>Xenograft tolerance</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA. Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Xenotransplantation 2006; 13: 224–232. © Blackwell Munksgaard, 2006 Abstract:  Background:  The induction of xenogeneic hematopoietic chimerism is an attractive approach for overcoming the host response to xenografts, but establishing xenogeneic chimerism requires severe myeloablative conditioning of the recipient. The goal of this study was to determine if co‐stimulation blockade would facilitate chimerism and xenograft tolerance in irradiation‐conditioned concordant recipients. Methods:  Wistar Furth rat bone marrow (BM) cells were injected into irradiation‐conditioned C57BL/6 mice with or without co‐administration of anti‐mouse CD154 monoclonal antibody (mAb). Chimerism was quantified by flow cytometry, and mice were transplanted with WF rat skin and islet xenografts. Results:  Blockade of CD40–CD154 interaction facilitated establishment of xenogeneic chimerism in mice conditioned with 600 cGy irradiation. Anti‐CD154 mAb was not required for establishment of chimerism in mice treated with 700 cGy. However, mice irradiated with 700 cGy but not treated with anti‐CD154 mAb developed a “graft‐versus‐host disease (GVHD)‐like” wasting syndrome and died, irrespective of their development of chimerism. Xenogeneic chimeras established with irradiation and anti‐CD154 mAb treatment exhibited prolonged skin and, in many cases, permanent islet xenograft survival. Chimerism was unstable and eventually lost in most recipients. Skin xenografts were rejected even in mice that remained chimeric, whereas most islet xenografts survived to the end of the observation period. Conclusions:  Blockade of host CD40–CD154 interaction facilitates the establishment of xenogeneic chimerism and prevents wasting disease and death. Chimerism permits prolonged xenograft survival, but chimerism generated in this way is unstable over time. Skin xenografts are eventually rejected, whereas most islet xenografts survive long term and perhaps permanently.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<keywords>
<teeft>
<json:string>chimerism</json:string>
<json:string>xenograft</json:string>
<json:string>xenogeneic</json:string>
<json:string>islet</json:string>
<json:string>transplantation</json:string>
<json:string>hematopoietic</json:string>
<json:string>chimeric</json:string>
<json:string>allogeneic</json:string>
<json:string>xenogeneic hematopoietic chimerism</json:string>
<json:string>chimeric mice</json:string>
<json:string>xenogeneic chimerism</json:string>
<json:string>bone marrow</json:string>
<json:string>rt1a</json:string>
<json:string>islet xenografts</json:string>
<json:string>monoclonal antibody</json:string>
<json:string>monoclonal</json:string>
<json:string>skin xenografts</json:string>
<json:string>immunol</json:string>
<json:string>allograft</json:string>
<json:string>pbmc</json:string>
<json:string>graft</json:string>
<json:string>chimera</json:string>
<json:string>gvhd</json:string>
<json:string>islet xenograft survival</json:string>
<json:string>hematopoietic chimerism</json:string>
<json:string>wistar</json:string>
<json:string>furth</json:string>
<json:string>xenograft survival</json:string>
<json:string>allogeneic hematopoietic chimerism</json:string>
<json:string>mouse</json:string>
<json:string>peripheral blood</json:string>
<json:string>cell transplantation</json:string>
<json:string>deletional tolerance</json:string>
<json:string>transplantation tolerance</json:string>
<json:string>cell injection</json:string>
<json:string>wistar furth</json:string>
<json:string>central tolerance</json:string>
<json:string>skin xenograft survival</json:string>
<json:string>regimen</json:string>
<json:string>syndrome</json:string>
<json:string>becton dickinson</json:string>
<json:string>permanent islet xenograft survival</json:string>
<json:string>xenograft tolerance</json:string>
<json:string>skin grafts</json:string>
<json:string>plasma glucose concentration</json:string>
<json:string>graft survival</json:string>
<json:string>host interaction</json:string>
<json:string>conditioning regimen</json:string>
<json:string>long term</json:string>
<json:string>many cases</json:string>
<json:string>chimeric animals</json:string>
<json:string>costimulation blockade</json:string>
<json:string>recipient mice</json:string>
<json:string>observation period</json:string>
<json:string>costimulatory blockade</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>Hideyuki Masaki</name>
<affiliations>
<json:string>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Michael C. Appel</name>
<affiliations>
<json:string>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Linda Leahy</name>
<affiliations>
<json:string>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Jean Leif</name>
<affiliations>
<json:string>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Linda Paquin</name>
<affiliations>
<json:string>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Leonard D. Shultz</name>
<affiliations>
<json:string>The Jackson Laboratory, Bar Harbor, ME, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>John P. Mordes</name>
<affiliations>
<json:string>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Dale L. Greiner</name>
<affiliations>
<json:string>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Aldo A. Rossini</name>
<affiliations>
<json:string>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>CD154</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hematopoietic chimeras</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>islet</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mouse</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>rat</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>skin</value>
</json:item>
</subject>
<articleId>
<json:string>XEN290</json:string>
</articleId>
<arkIstex>ark:/67375/WNG-MLTTS251-R</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>article</json:string>
</originalGenre>
<abstract>Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA. Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.Xenotransplantation 2006; 13: 224–232. © Blackwell Munksgaard, 2006 Abstract:  Background:  The induction of xenogeneic hematopoietic chimerism is an attractive approach for overcoming the host response to xenografts, but establishing xenogeneic chimerism requires severe myeloablative conditioning of the recipient. The goal of this study was to determine if co‐stimulation blockade would facilitate chimerism and xenograft tolerance in irradiation‐conditioned concordant recipients. Methods:  Wistar Furth rat bone marrow (BM) cells were injected into irradiation‐conditioned C57BL/6 mice with or without co‐administration of anti‐mouse CD154 monoclonal antibody (mAb). Chimerism was quantified by flow cytometry, and mice were transplanted with WF rat skin and islet xenografts. Results:  Blockade of CD40–CD154 interaction facilitated establishment of xenogeneic chimerism in mice conditioned with 600 cGy irradiation. Anti‐CD154 mAb was not required for establishment of chimerism in mice treated with 700 cGy. However, mice irradiated with 700 cGy but not treated with anti‐CD154 mAb developed a “graft‐versus‐host disease (GVHD)‐like” wasting syndrome and died, irrespective of their development of chimerism. Xenogeneic chimeras established with irradiation and anti‐CD154 mAb treatment exhibited prolonged skin and, in many cases, permanent islet xenograft survival. Chimerism was unstable and eventually lost in most recipients. Skin xenografts were rejected even in mice that remained chimeric, whereas most islet xenografts survived to the end of the observation period. Conclusions:  Blockade of host CD40–CD154 interaction facilitates the establishment of xenogeneic chimerism and prevents wasting disease and death. Chimerism permits prolonged xenograft survival, but chimerism generated in this way is unstable over time. Skin xenografts are eventually rejected, whereas most islet xenografts survive long term and perhaps permanently.</abstract>
<qualityIndicators>
<score>10</score>
<pdfWordCount>5390</pdfWordCount>
<pdfCharCount>35582</pdfCharCount>
<pdfVersion>1.4</pdfVersion>
<pdfPageCount>9</pdfPageCount>
<pdfPageSize>595 x 782 pts</pdfPageSize>
<pdfWordsPerPage>599</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>true</refBibsNative>
<abstractWordCount>293</abstractWordCount>
<abstractCharCount>2218</abstractCharCount>
<keywordCount>6</keywordCount>
</qualityIndicators>
<title>Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice</title>
<pmid>
<json:string>16756565</json:string>
</pmid>
<genre>
<json:string>article</json:string>
</genre>
<host>
<title>Xenotransplantation</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1111/(ISSN)1399-3089</json:string>
</doi>
<issn>
<json:string>0908-665X</json:string>
</issn>
<eissn>
<json:string>1399-3089</json:string>
</eissn>
<publisherId>
<json:string>XEN</json:string>
</publisherId>
<volume>13</volume>
<issue>3</issue>
<pages>
<first>224</first>
<last>232</last>
<total>9</total>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<namedEntities>
<unitex>
<date>
<json:string>2006</json:string>
</date>
<geogName></geogName>
<orgName>
<json:string>Use Committee of the University of Massachusetts Medical School</json:string>
<json:string>National Cancer Institute, Frederick MD</json:string>
<json:string>National Institutes of Health and grant</json:string>
<json:string>Division of Diabetes</json:string>
<json:string>Roche Diagnostics, Indianapolis</json:string>
<json:string>Laboratory Animals</json:string>
<json:string>University of Massachusetts Medical School</json:string>
<json:string>Biotech</json:string>
<json:string>Diabetes Endocrinology Research Center</json:string>
<json:string>DERC</json:string>
<json:string>National Institutes of Health</json:string>
<json:string>Jackson Laboratory, Bar Harbor, ME, USA Key</json:string>
<json:string>Canada, Ottawa, Ontario, Canada</json:string>
<json:string>Pharmingen</json:string>
<json:string>National Institute of Diabetes and Digestive</json:string>
<json:string>National Cell Culture Center</json:string>
<json:string>Juvenile Diabetes Foundation, International</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName>
<json:string>Linda Paquin</json:string>
<json:string>Franklin Lakes</json:string>
<json:string>Energy</json:string>
<json:string>Leonard D. Shultz</json:string>
<json:string>Aldo A. Rossini</json:string>
<json:string>Elaine Norowski</json:string>
<json:string>Linda Leahy</json:string>
<json:string>Jean Leif</json:string>
<json:string>Dale L. Greiner</json:string>
<json:string>John P. Mordes</json:string>
</persName>
<placeName>
<json:string>Minneapolis</json:string>
<json:string>San Diego</json:string>
<json:string>Charleston</json:string>
<json:string>SC</json:string>
<json:string>San Jose</json:string>
<json:string>USA</json:string>
<json:string>Puri</json:string>
<json:string>CA</json:string>
<json:string>Roswell</json:string>
<json:string>MA</json:string>
<json:string>Indianapolis</json:string>
<json:string>IN.</json:string>
<json:string>Worcester</json:string>
<json:string>MN</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl>
<json:string>[7,8]</json:string>
<json:string>[34]</json:string>
<json:string>[25,32,42]</json:string>
<json:string>[26,27]</json:string>
<json:string>Masaki et al.</json:string>
<json:string>[29]</json:string>
<json:string>[6]</json:string>
<json:string>[11]</json:string>
<json:string>[39]</json:string>
<json:string>[43]</json:string>
<json:string>[25,30,31]</json:string>
<json:string>[38]</json:string>
<json:string>[9,10]</json:string>
<json:string>[13,14]</json:string>
<json:string>[26]</json:string>
<json:string>[8,36,37]</json:string>
<json:string>[41]</json:string>
<json:string>Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences, 1996</json:string>
<json:string>[13,21,22]</json:string>
<json:string>[9]</json:string>
<json:string>[1,2]</json:string>
<json:string>[40]</json:string>
<json:string>[35]</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/WNG-MLTTS251-R</json:string>
</ark>
<categories>
<wos>
<json:string>1 - science</json:string>
<json:string>2 - transplantation</json:string>
<json:string>2 - medicine, research & experimental</json:string>
</wos>
<scienceMetrix>
<json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - surgery</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Transplantation</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Immunology and Microbiology</json:string>
<json:string>3 - Immunology</json:string>
</scopus>
<inist>
<json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
</inist>
</categories>
<publicationDate>2006</publicationDate>
<copyrightDate>2006</copyrightDate>
<doi>
<json:string>10.1111/j.1399-3089.2006.00290.x</json:string>
</doi>
<id>FA45E49EAD425063F681D804106E110FBF006EBC</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-MLTTS251-R/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-MLTTS251-R/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-MLTTS251-R/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main">Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice</title>
<title level="a" type="short">Co‐stimulation and xenogeneic chimerism</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<availability>
<licence>Copyright © Blackwell Munksgaard 2006</licence>
</availability>
<date type="published" when="2006-05"></date>
</publicationStmt>
<notesStmt>
<note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct type="article">
<analytic>
<title level="a" type="main">Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice</title>
<title level="a" type="short">Co‐stimulation and xenogeneic chimerism</title>
<author xml:id="author-0000">
<persName>
<forename type="first">Hideyuki</forename>
<surname>Masaki</surname>
</persName>
<affiliation>
<orgName type="division">Division of Diabetes</orgName>
<orgName type="institution">University of Massachusetts Medical School</orgName>
<address>
<addrLine>Worcester</addrLine>
<addrLine>MA, USA</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">Michael C.</forename>
<surname>Appel</surname>
</persName>
<affiliation>
<orgName type="division">Division of Diabetes</orgName>
<orgName type="institution">University of Massachusetts Medical School</orgName>
<address>
<addrLine>Worcester</addrLine>
<addrLine>MA, USA</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">Linda</forename>
<surname>Leahy</surname>
</persName>
<affiliation>
<orgName type="division">Division of Diabetes</orgName>
<orgName type="institution">University of Massachusetts Medical School</orgName>
<address>
<addrLine>Worcester</addrLine>
<addrLine>MA, USA</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<author xml:id="author-0003">
<persName>
<forename type="first">Jean</forename>
<surname>Leif</surname>
</persName>
<affiliation>
<orgName type="division">Division of Diabetes</orgName>
<orgName type="institution">University of Massachusetts Medical School</orgName>
<address>
<addrLine>Worcester</addrLine>
<addrLine>MA, USA</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<author xml:id="author-0004">
<persName>
<forename type="first">Linda</forename>
<surname>Paquin</surname>
</persName>
<affiliation>
<orgName type="division">Division of Diabetes</orgName>
<orgName type="institution">University of Massachusetts Medical School</orgName>
<address>
<addrLine>Worcester</addrLine>
<addrLine>MA, USA</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<author xml:id="author-0005">
<persName>
<forename type="first">Leonard D.</forename>
<surname>Shultz</surname>
</persName>
<affiliation>
<orgName type="laboratory">The Jackson Laboratory</orgName>
<address>
<addrLine>Bar Harbor</addrLine>
<addrLine>ME, USA</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<author xml:id="author-0006">
<persName>
<forename type="first">John P.</forename>
<surname>Mordes</surname>
</persName>
<affiliation>
<orgName type="division">Division of Diabetes</orgName>
<orgName type="institution">University of Massachusetts Medical School</orgName>
<address>
<addrLine>Worcester</addrLine>
<addrLine>MA, USA</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<author xml:id="author-0007">
<persName>
<forename type="first">Dale L.</forename>
<surname>Greiner</surname>
</persName>
<affiliation>
<orgName type="division">Division of Diabetes</orgName>
<orgName type="institution">University of Massachusetts Medical School</orgName>
<address>
<addrLine>Worcester</addrLine>
<addrLine>MA, USA</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<author xml:id="author-0008">
<persName>
<forename type="first">Aldo A.</forename>
<surname>Rossini</surname>
</persName>
<affiliation>
<orgName type="division">Division of Diabetes</orgName>
<orgName type="institution">University of Massachusetts Medical School</orgName>
<address>
<addrLine>Worcester</addrLine>
<addrLine>MA, USA</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<idno type="istex">FA45E49EAD425063F681D804106E110FBF006EBC</idno>
<idno type="ark">ark:/67375/WNG-MLTTS251-R</idno>
<idno type="DOI">10.1111/j.1399-3089.2006.00290.x</idno>
<idno type="unit">XEN290</idno>
<idno type="toTypesetVersion">file:XEN.XEN290.pdf</idno>
</analytic>
<monogr>
<title level="j" type="main">Xenotransplantation</title>
<title level="j" type="alt">XENOTRANSPLANTATION</title>
<idno type="pISSN">0908-665X</idno>
<idno type="eISSN">1399-3089</idno>
<idno type="book-DOI">10.1111/(ISSN)1399-3089</idno>
<idno type="book-part-DOI">10.1111/xen.2006.13.issue-3</idno>
<idno type="product">XEN</idno>
<idno type="publisherDivision">ST</idno>
<imprint>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="224">224</biblScope>
<biblScope unit="page" to="232">232</biblScope>
<biblScope unit="page-count">9</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2006-05"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc>
<schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo>
<application ident="pub2tei" version="1.0.10" when="2019-12-20">
<label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc>
<abstract xml:lang="en" style="main">
<p>Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA. Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Xenotransplantation 2006; 13: 224–232. © Blackwell Munksgaard, 2006</p>
<p>
<hi rend="bold">Abstract: </hi>
<hi rend="bold"> Background: </hi>
The induction of xenogeneic hematopoietic chimerism is an attractive approach for overcoming the host response to xenografts, but establishing xenogeneic chimerism requires severe myeloablative conditioning of the recipient. The goal of this study was to determine if co‐stimulation blockade would facilitate chimerism and xenograft tolerance in irradiation‐conditioned concordant recipients.</p>
<p>
<hi rend="bold">Methods: </hi>
Wistar Furth rat bone marrow (BM) cells were injected into irradiation‐conditioned C57BL/6 mice with or without co‐administration of anti‐mouse CD154 monoclonal antibody (mAb). Chimerism was quantified by flow cytometry, and mice were transplanted with WF rat skin and islet xenografts.</p>
<p>
<hi rend="bold">Results: </hi>
Blockade of CD40–CD154 interaction facilitated establishment of xenogeneic chimerism in mice conditioned with 600 cGy irradiation. Anti‐CD154 mAb was not required for establishment of chimerism in mice treated with 700 cGy. However, mice irradiated with 700 cGy but not treated with anti‐CD154 mAb developed a “graft‐versus‐host disease (GVHD)‐like” wasting syndrome and died, irrespective of their development of chimerism. Xenogeneic chimeras established with irradiation and anti‐CD154 mAb treatment exhibited prolonged skin and, in many cases, permanent islet xenograft survival. Chimerism was unstable and eventually lost in most recipients. Skin xenografts were rejected even in mice that remained chimeric, whereas most islet xenografts survived to the end of the observation period.</p>
<p>
<hi rend="bold">Conclusions: </hi>
Blockade of host CD40–CD154 interaction facilitates the establishment of xenogeneic chimerism and prevents wasting disease and death. Chimerism permits prolonged xenograft survival, but chimerism generated in this way is unstable over time. Skin xenografts are eventually rejected, whereas most islet xenografts survive long term and perhaps permanently.</p>
</abstract>
<textClass>
<keywords xml:lang="en">
<term xml:id="k1">CD154</term>
<term xml:id="k2">hematopoietic chimeras</term>
<term xml:id="k3">islet</term>
<term xml:id="k4">mouse</term>
<term xml:id="k5">rat</term>
<term xml:id="k6">skin</term>
</keywords>
<keywords rend="tocHeading1">
<term>Original Articles</term>
</keywords>
</textClass>
<langUsage>
<language ident="en"></language>
</langUsage>
</profileDesc>
<revisionDesc>
<change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-MLTTS251-R/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Blackwell Publishing Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1399-3089</doi>
<issn type="print">0908-665X</issn>
<issn type="electronic">1399-3089</issn>
<idGroup>
<id type="product" value="XEN"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup>
<title type="main" sort="XENOTRANSPLANTATION">Xenotransplantation</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="05003">
<doi origin="wiley">10.1111/xen.2006.13.issue-3</doi>
<numberingGroup>
<numbering type="journalVolume" number="13">13</numbering>
<numbering type="journalIssue" number="3">3</numbering>
</numberingGroup>
<coverDate startDate="2006-05">May 2006</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="10" status="forIssue">
<doi origin="wiley">10.1111/j.1399-3089.2006.00290.x</doi>
<idGroup>
<id type="unit" value="XEN290"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="9"></count>
</countGroup>
<titleGroup>
<title type="tocHeading1">O
<sc>riginal</sc>
A
<sc>rticles</sc>
</title>
</titleGroup>
<copyright>Copyright © Blackwell Munksgaard 2006</copyright>
<eventGroup>
<event type="firstOnline" date="2006-04-20"></event>
<event type="publishedOnlineFinalForm" date="2006-05-31"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.3 mode:FullText source:FullText result:FullText" date="2010-03-18"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-10"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-04"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst" number="224">224</numbering>
<numbering type="pageLast" number="232">232</numbering>
</numberingGroup>
<correspondenceTo>Address reprint requests to Aldo A. Rossini, 373 Plantation Street, Biotech 2, Suite 218, Worcester, MA 01605, USA
(E‐mail:
<email>aldo.rossini@umassmed.edu</email>
)</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:XEN.XEN290.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<unparsedEditorialHistory>Received 29 September 2005; Accepted 10 January 2006</unparsedEditorialHistory>
<countGroup>
<count type="figureTotal" number="5"></count>
<count type="tableTotal" number="1"></count>
<count type="formulaTotal" number="0"></count>
<count type="referenceTotal" number="43"></count>
<count type="linksCrossRef" number="66"></count>
</countGroup>
<titleGroup>
<title type="main">Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice</title>
<title type="shortAuthors">
<b>Masaki et al.</b>
</title>
<title type="short">
<b>Co‐stimulation and xenogeneic chimerism</b>
</title>
</titleGroup>
<creators>
<creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" noteRef="#fn1">
<personName>
<givenNames>Hideyuki</givenNames>
<familyName>Masaki</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr2" affiliationRef="#a1" noteRef="#fn2">
<personName>
<givenNames>Michael C.</givenNames>
<familyName>Appel</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr3" affiliationRef="#a1">
<personName>
<givenNames>Linda</givenNames>
<familyName>Leahy</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr4" affiliationRef="#a1">
<personName>
<givenNames>Jean</givenNames>
<familyName>Leif</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr5" affiliationRef="#a1">
<personName>
<givenNames>Linda</givenNames>
<familyName>Paquin</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr6" affiliationRef="#a2">
<personName>
<givenNames>Leonard D.</givenNames>
<familyName>Shultz</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr7" affiliationRef="#a1">
<personName>
<givenNames>John P.</givenNames>
<familyName>Mordes</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr8" affiliationRef="#a1">
<personName>
<givenNames>Dale L.</givenNames>
<familyName>Greiner</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr9" affiliationRef="#a1">
<personName>
<givenNames>Aldo A.</givenNames>
<familyName>Rossini</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="a1" countryCode="US">
<unparsedAffiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="a2" countryCode="US">
<unparsedAffiliation>The Jackson Laboratory, Bar Harbor, ME, USA</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en">
<keyword xml:id="k1">CD154</keyword>
<keyword xml:id="k2">hematopoietic chimeras</keyword>
<keyword xml:id="k3">islet</keyword>
<keyword xml:id="k4">mouse</keyword>
<keyword xml:id="k5">rat</keyword>
<keyword xml:id="k6">skin</keyword>
</keywordGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<p>Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA. Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Xenotransplantation 2006; 13: 224–232. © Blackwell Munksgaard, 2006</p>
<p>
<b>Abstract: </b>
<b> Background: </b>
The induction of xenogeneic hematopoietic chimerism is an attractive approach for overcoming the host response to xenografts, but establishing xenogeneic chimerism requires severe myeloablative conditioning of the recipient. The goal of this study was to determine if co‐stimulation blockade would facilitate chimerism and xenograft tolerance in irradiation‐conditioned concordant recipients.</p>
<p>
<b>Methods: </b>
Wistar Furth rat bone marrow (BM) cells were injected into irradiation‐conditioned C57BL/6 mice with or without co‐administration of anti‐mouse CD154 monoclonal antibody (mAb). Chimerism was quantified by flow cytometry, and mice were transplanted with WF rat skin and islet xenografts.</p>
<p>
<b>Results: </b>
Blockade of CD40–CD154 interaction facilitated establishment of xenogeneic chimerism in mice conditioned with 600 cGy irradiation. Anti‐CD154 mAb was not required for establishment of chimerism in mice treated with 700 cGy. However, mice irradiated with 700 cGy but not treated with anti‐CD154 mAb developed a “graft‐versus‐host disease (GVHD)‐like” wasting syndrome and died, irrespective of their development of chimerism. Xenogeneic chimeras established with irradiation and anti‐CD154 mAb treatment exhibited prolonged skin and, in many cases, permanent islet xenograft survival. Chimerism was unstable and eventually lost in most recipients. Skin xenografts were rejected even in mice that remained chimeric, whereas most islet xenografts survived to the end of the observation period.</p>
<p>
<b>Conclusions: </b>
Blockade of host CD40–CD154 interaction facilitates the establishment of xenogeneic chimerism and prevents wasting disease and death. Chimerism permits prolonged xenograft survival, but chimerism generated in this way is unstable over time. Skin xenografts are eventually rejected, whereas most islet xenografts survive long term and perhaps permanently.</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup>
<note xml:id="fn1">
<label>*</label>
<p> Present address: First Department of Biochemistry, Kinki University School of Medicine, Osaka‐Sayama, Japan.</p>
</note>
<note xml:id="fn2">
<label>
<sup></sup>
</label>
<p> Present address: National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Co‐stimulation and xenogeneic chimerism</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice</title>
</titleInfo>
<name type="personal">
<namePart type="given">Hideyuki</namePart>
<namePart type="family">Masaki</namePart>
<affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</affiliation>
<description>Present address: First Department of Biochemistry, Kinki University School of Medicine, Osaka‐Sayama, Japan.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Michael C.</namePart>
<namePart type="family">Appel</namePart>
<affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</affiliation>
<description>Present address: National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Linda</namePart>
<namePart type="family">Leahy</namePart>
<affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Jean</namePart>
<namePart type="family">Leif</namePart>
<affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Linda</namePart>
<namePart type="family">Paquin</namePart>
<affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Leonard D.</namePart>
<namePart type="family">Shultz</namePart>
<affiliation>The Jackson Laboratory, Bar Harbor, ME, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">John P.</namePart>
<namePart type="family">Mordes</namePart>
<affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Dale L.</namePart>
<namePart type="family">Greiner</namePart>
<affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Aldo A.</namePart>
<namePart type="family">Rossini</namePart>
<affiliation>Division of Diabetes, University of Massachusetts Medical School, Worcester, MA, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre>
<originInfo>
<publisher>Blackwell Publishing Ltd</publisher>
<place>
<placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2006-05</dateIssued>
<edition>Received 29 September 2005; Accepted 10 January 2006</edition>
<copyrightDate encoding="w3cdtf">2006</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<extent unit="figures">5</extent>
<extent unit="tables">1</extent>
<extent unit="formulas">0</extent>
<extent unit="references">43</extent>
<extent unit="linksCrossRef">66</extent>
</physicalDescription>
<abstract lang="en">Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA. Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Xenotransplantation 2006; 13: 224–232. © Blackwell Munksgaard, 2006 Abstract:  Background:  The induction of xenogeneic hematopoietic chimerism is an attractive approach for overcoming the host response to xenografts, but establishing xenogeneic chimerism requires severe myeloablative conditioning of the recipient. The goal of this study was to determine if co‐stimulation blockade would facilitate chimerism and xenograft tolerance in irradiation‐conditioned concordant recipients. Methods:  Wistar Furth rat bone marrow (BM) cells were injected into irradiation‐conditioned C57BL/6 mice with or without co‐administration of anti‐mouse CD154 monoclonal antibody (mAb). Chimerism was quantified by flow cytometry, and mice were transplanted with WF rat skin and islet xenografts. Results:  Blockade of CD40–CD154 interaction facilitated establishment of xenogeneic chimerism in mice conditioned with 600 cGy irradiation. Anti‐CD154 mAb was not required for establishment of chimerism in mice treated with 700 cGy. However, mice irradiated with 700 cGy but not treated with anti‐CD154 mAb developed a “graft‐versus‐host disease (GVHD)‐like” wasting syndrome and died, irrespective of their development of chimerism. Xenogeneic chimeras established with irradiation and anti‐CD154 mAb treatment exhibited prolonged skin and, in many cases, permanent islet xenograft survival. Chimerism was unstable and eventually lost in most recipients. Skin xenografts were rejected even in mice that remained chimeric, whereas most islet xenografts survived to the end of the observation period. Conclusions:  Blockade of host CD40–CD154 interaction facilitates the establishment of xenogeneic chimerism and prevents wasting disease and death. Chimerism permits prolonged xenograft survival, but chimerism generated in this way is unstable over time. Skin xenografts are eventually rejected, whereas most islet xenografts survive long term and perhaps permanently.</abstract>
<subject lang="en">
<genre>keywords</genre>
<topic>CD154</topic>
<topic>hematopoietic chimeras</topic>
<topic>islet</topic>
<topic>mouse</topic>
<topic>rat</topic>
<topic>skin</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Xenotransplantation</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<identifier type="ISSN">0908-665X</identifier>
<identifier type="eISSN">1399-3089</identifier>
<identifier type="DOI">10.1111/(ISSN)1399-3089</identifier>
<identifier type="PublisherID">XEN</identifier>
<part>
<date>2006</date>
<detail type="volume">
<caption>vol.</caption>
<number>13</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>3</number>
</detail>
<extent unit="pages">
<start>224</start>
<end>232</end>
<total>9</total>
</extent>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit1">
<titleInfo>
<title>Application of xenogeneic stem cells for induction of transplantation tolerance</title>
</titleInfo>
<name type="personal">
<namePart type="given">YG</namePart>
<namePart type="family">Yang</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Yang YG. Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions. Springer Semin Immunopathol 2004; 26: 187.</note>
<part>
<date>2004</date>
<detail type="volume">
<caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages">
<start>187</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>present state and future directions</title>
</titleInfo>
<part>
<date>2004</date>
<detail type="volume">
<caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages">
<start>187</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit2">
<titleInfo>
<title>Which patients first? Planning the first clinical trial of xenotransplantation</title>
</titleInfo>
<name type="personal">
<namePart type="given">Z</namePart>
<namePart type="family">Ibrahim</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Ezzelarab</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R</namePart>
<namePart type="family">Kormos</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ibrahim Z, Ezzelarab M, Kormos R et al. Which patients first? Planning the first clinical trial of xenotransplantation: a case for cardiac bridging. Xenotransplantation 2005; 12: 168.</note>
<part>
<date>2005</date>
<detail type="volume">
<caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages">
<start>168</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>a case for cardiac bridging</title>
</titleInfo>
<part>
<date>2005</date>
<detail type="volume">
<caption>vol.</caption>
<number>12</number>
</detail>
<extent unit="pages">
<start>168</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit3">
<titleInfo>
<title>The immunological barrier to xenotransplantation</title>
</titleInfo>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Cascalho</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">JL</namePart>
<namePart type="family">Platt</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Cascalho M, Platt JL. The immunological barrier to xenotransplantation. Immunity 2001; 14: 437.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages">
<start>437</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Immunity</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages">
<start>437</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit4">
<titleInfo>
<title>Cooper DK, Lanza RP. Xeno: The Promise of Transplanting Animal Organs into Humans. Oxford, UK: Oxford University Press, 2000.</title>
</titleInfo>
<note type="citation/reference">Cooper DK, Lanza RP. Xeno: The Promise of Transplanting Animal Organs into Humans. Oxford, UK: Oxford University Press, 2000.</note>
<name type="personal">
<namePart type="given">DK</namePart>
<namePart type="family">Cooper</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">RP</namePart>
<namePart type="family">Lanza</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book</genre>
<originInfo>
<publisher>Oxford University Press</publisher>
</originInfo>
<part>
<date>2000</date>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit5">
<titleInfo>
<title>Xenograft rejection</title>
</titleInfo>
<name type="personal">
<namePart type="given">R</namePart>
<namePart type="family">Rieben</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">JD</namePart>
<namePart type="family">Seebach</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Rieben R, Seebach JD. Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. Trends Immunol 2005; 26: 2.</note>
<part>
<date>2005</date>
<detail type="volume">
<caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages">
<start>2</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>IgG1, complement and NK cells team up to activate and destroy the endothelium</title>
</titleInfo>
<part>
<date>2005</date>
<detail type="volume">
<caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages">
<start>2</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit6">
<titleInfo>
<title>Production of alpha 1,3‐galactosyltransferase‐deficient pigs</title>
</titleInfo>
<name type="personal">
<namePart type="given">CJ</namePart>
<namePart type="family">Phelps</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C</namePart>
<namePart type="family">Koike</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">TD</namePart>
<namePart type="family">Vaught</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Phelps CJ, Koike C, Vaught TD et al. Production of alpha 1,3‐galactosyltransferase‐deficient pigs. Science 2003; 299: 411.</note>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>299</number>
</detail>
<extent unit="pages">
<start>411</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Science</title>
</titleInfo>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>299</number>
</detail>
<extent unit="pages">
<start>411</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit7">
<titleInfo>
<title>Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance</title>
</titleInfo>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Sykes</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">I</namePart>
<namePart type="family">Shimizu</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">T</namePart>
<namePart type="family">Kawahara</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sykes M, Shimizu I, Kawahara T. Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance. Transplantation 2005; 79: S28.</note>
<part>
<date>2005</date>
<detail type="volume">
<caption>vol.</caption>
<number>79</number>
</detail>
<extent unit="pages">
<start>S28</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Transplantation</title>
</titleInfo>
<part>
<date>2005</date>
<detail type="volume">
<caption>vol.</caption>
<number>79</number>
</detail>
<extent unit="pages">
<start>S28</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit8">
<titleInfo>
<title>Mixed xenogeneic chimerism induces donor‐specific humoral and cellular immune tolerance for cardiac xenografts</title>
</titleInfo>
<name type="personal">
<namePart type="given">YL</namePart>
<namePart type="family">Colson</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H</namePart>
<namePart type="family">Xu</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Y</namePart>
<namePart type="family">Huang</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Colson YL, Xu H, Huang Y et al. Mixed xenogeneic chimerism induces donor‐specific humoral and cellular immune tolerance for cardiac xenografts. J Immunol 2004; 173: 5827.</note>
<part>
<date>2004</date>
<detail type="volume">
<caption>vol.</caption>
<number>173</number>
</detail>
<extent unit="pages">
<start>5827</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Immunol</title>
</titleInfo>
<part>
<date>2004</date>
<detail type="volume">
<caption>vol.</caption>
<number>173</number>
</detail>
<extent unit="pages">
<start>5827</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit9">
<titleInfo>
<title>Specific tolerance induction across a xenogeneic barrier</title>
</titleInfo>
<name type="personal">
<namePart type="given">Y</namePart>
<namePart type="family">Sharabi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">I</namePart>
<namePart type="family">Aksentijevich</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">TM</namePart>
<namePart type="family">Sundt III</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sharabi Y, Aksentijevich I, Sundt TM III et al. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>172</number>
</detail>
<extent unit="pages">
<start>195</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>172</number>
</detail>
<extent unit="pages">
<start>195</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit10">
<titleInfo>
<title>Long‐term survival of cardiac xenografts in fully xenogeneic (mouse→rat) bone marrow chimeras</title>
</titleInfo>
<name type="personal">
<namePart type="given">MM</namePart>
<namePart type="family">Mohiuddin</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Y</namePart>
<namePart type="family">Qin</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">XH</namePart>
<namePart type="family">Qian</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Mohiuddin MM, Qin Y, Qian XH et al. Long‐term survival of cardiac xenografts in fully xenogeneic (mouse→rat) bone marrow chimeras. Ann Thorac Surg 2001; 72: 740.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages">
<start>740</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Ann Thorac Surg</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages">
<start>740</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit11">
<titleInfo>
<title>Controlling the incidence of infection and malignancy by modifying immunosuppression</title>
</titleInfo>
<name type="personal">
<namePart type="given">JP</namePart>
<namePart type="family">Soulillou</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Giral</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Soulillou JP, Giral M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 2001; 72: S89.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages">
<start>S89</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Transplantation</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages">
<start>S89</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit12">
<titleInfo>
<title>Induction of immunological tolerance for transplantation</title>
</titleInfo>
<name type="personal">
<namePart type="given">AA</namePart>
<namePart type="family">Rossini</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">DL</namePart>
<namePart type="family">Greiner</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">JP</namePart>
<namePart type="family">Mordes</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Rossini AA, Greiner DL, Mordes JP. Induction of immunological tolerance for transplantation. Physiol Rev 1999; 79: 99.</note>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>79</number>
</detail>
<extent unit="pages">
<start>99</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Physiol Rev</title>
</titleInfo>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>79</number>
</detail>
<extent unit="pages">
<start>99</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit13">
<titleInfo>
<title>Hematopoietic chimerism and central tolerance created by peripheral tolerance induction without myeloablative conditioning</title>
</titleInfo>
<name type="personal">
<namePart type="given">E</namePart>
<namePart type="family">Seung</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">JP</namePart>
<namePart type="family">Mordes</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">AA</namePart>
<namePart type="family">Rossini</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Seung E, Mordes JP, Rossini AA et al. Hematopoietic chimerism and central tolerance created by peripheral tolerance induction without myeloablative conditioning. J Clin Invest 2003; 112: 795.</note>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>112</number>
</detail>
<extent unit="pages">
<start>795</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Clin Invest</title>
</titleInfo>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>112</number>
</detail>
<extent unit="pages">
<start>795</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit14">
<titleInfo>
<title>Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms</title>
</titleInfo>
<name type="personal">
<namePart type="given">D</namePart>
<namePart type="family">Forman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">RM</namePart>
<namePart type="family">Welsh</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">TG</namePart>
<namePart type="family">Markees</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Forman D, Welsh RM, Markees TG et al. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms. J Immunol 2002; 168: 6047.</note>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>168</number>
</detail>
<extent unit="pages">
<start>6047</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Immunol</title>
</titleInfo>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>168</number>
</detail>
<extent unit="pages">
<start>6047</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit15">
<titleInfo>
<title>Mixed chimerism and transplant tolerance</title>
</titleInfo>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Sykes</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001; 14: 417.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages">
<start>417</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Immunity</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages">
<start>417</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit16">
<titleInfo>
<title>Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti‐CD154 antibody</title>
</titleInfo>
<name type="personal">
<namePart type="given">E</namePart>
<namePart type="family">Seung</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N</namePart>
<namePart type="family">Iwakoshi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">BA</namePart>
<namePart type="family">Woda</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Seung E, Iwakoshi N, Woda BA et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti‐CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000; 95: 2175.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>95</number>
</detail>
<extent unit="pages">
<start>2175</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>95</number>
</detail>
<extent unit="pages">
<start>2175</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit17">
<titleInfo>
<title>Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation‐induced cell death and passive cell death</title>
</titleInfo>
<name type="personal">
<namePart type="given">T</namePart>
<namePart type="family">Wekerle</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Kurtz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MH</namePart>
<namePart type="family">Sayegh</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wekerle T, Kurtz J, Sayegh MH et al. Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation‐induced cell death and passive cell death. J Immunol 2001; 166: 2311.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>166</number>
</detail>
<extent unit="pages">
<start>2311</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Immunol</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>166</number>
</detail>
<extent unit="pages">
<start>2311</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit18">
<titleInfo>
<title>Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance</title>
</titleInfo>
<name type="personal">
<namePart type="given">T</namePart>
<namePart type="family">Wekerle</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MH</namePart>
<namePart type="family">Sayegh</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Hill</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wekerle T, Sayegh MH, Hill J et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998; 187: 2037.</note>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>187</number>
</detail>
<extent unit="pages">
<start>2037</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Exp Med</title>
</titleInfo>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>187</number>
</detail>
<extent unit="pages">
<start>2037</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit19">
<titleInfo>
<title>Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression</title>
</titleInfo>
<name type="personal">
<namePart type="given">AB</namePart>
<namePart type="family">Adams</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MM</namePart>
<namePart type="family">Durham</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">L</namePart>
<namePart type="family">Kean</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Adams AB, Durham MM, Kean L et al. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J Immunol 2001; 167: 1103.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>167</number>
</detail>
<extent unit="pages">
<start>1103</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Immunol</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>167</number>
</detail>
<extent unit="pages">
<start>1103</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit20">
<titleInfo>
<title>Requirements for the promotion of allogeneic engraftment by anti‐CD154 (anti‐CD40L) monoclonal antibody under nonmyeloablative conditions</title>
</titleInfo>
<name type="personal">
<namePart type="given">PA</namePart>
<namePart type="family">Taylor</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">CJ</namePart>
<namePart type="family">Lees</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H</namePart>
<namePart type="family">Waldmann</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Taylor PA, Lees CJ, Waldmann H et al. Requirements for the promotion of allogeneic engraftment by anti‐CD154 (anti‐CD40L) monoclonal antibody under nonmyeloablative conditions. Blood 2001; 98: 467.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>98</number>
</detail>
<extent unit="pages">
<start>467</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Blood</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>98</number>
</detail>
<extent unit="pages">
<start>467</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit21">
<titleInfo>
<title>Cutting edge</title>
</titleInfo>
<name type="personal">
<namePart type="given">MM</namePart>
<namePart type="family">Durham</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">AW</namePart>
<namePart type="family">Bingaman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">AB</namePart>
<namePart type="family">Adams</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Durham MM, Bingaman AW, Adams AB et al. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol 2000; 165: 1.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>165</number>
</detail>
<extent unit="pages">
<start>1</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>165</number>
</detail>
<extent unit="pages">
<start>1</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit22">
<titleInfo>
<title>Allogeneic bone marrow transplantation with co‐stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment</title>
</titleInfo>
<name type="personal">
<namePart type="given">T</namePart>
<namePart type="family">Werkele</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Kurtz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H</namePart>
<namePart type="family">Ito</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Werkele T, Kurtz J, Ito H et al. Allogeneic bone marrow transplantation with co‐stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000; 6: 464.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages">
<start>464</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Nat Med</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages">
<start>464</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit23">
<titleInfo>
<title>Skin allograft maintenance in a new synchimeric model system of tolerance</title>
</titleInfo>
<name type="personal">
<namePart type="given">NN</namePart>
<namePart type="family">Iwakoshi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">TG</namePart>
<namePart type="family">Markees</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">NA</namePart>
<namePart type="family">Turgeon</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Iwakoshi NN, Markees TG, Turgeon NA et al. Skin allograft maintenance in a new synchimeric model system of tolerance. J Immunol 2001; 167: 6623.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>167</number>
</detail>
<extent unit="pages">
<start>6623</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Immunol</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>167</number>
</detail>
<extent unit="pages">
<start>6623</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit24">
<titleInfo>
<title>Long‐term survival of skin allografts induced by donor splenocytes and anti‐CD154 antibody in thymectomized mice requires CD4+ T cells, interferon‐gamma, and CTLA4</title>
</titleInfo>
<name type="personal">
<namePart type="given">TG</namePart>
<namePart type="family">Markees</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">NE</namePart>
<namePart type="family">Phillips</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">EJ</namePart>
<namePart type="family">Gordon</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Markees TG, Phillips NE, Gordon EJ et al. Long‐term survival of skin allografts induced by donor splenocytes and anti‐CD154 antibody in thymectomized mice requires CD4+ T cells, interferon‐gamma, and CTLA4. J Clin Invest 1998; 101: 2446.</note>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>101</number>
</detail>
<extent unit="pages">
<start>2446</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Clin Invest</title>
</titleInfo>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>101</number>
</detail>
<extent unit="pages">
<start>2446</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit25">
<titleInfo>
<title>Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand</title>
</titleInfo>
<name type="personal">
<namePart type="given">DC</namePart>
<namePart type="family">Parker</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">DL</namePart>
<namePart type="family">Greiner</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">NE</namePart>
<namePart type="family">Phillips</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Parker DC, Greiner DL, Phillips NE et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A 1995; 92: 9560.</note>
<part>
<date>1995</date>
<detail type="volume">
<caption>vol.</caption>
<number>92</number>
</detail>
<extent unit="pages">
<start>9560</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc Natl Acad Sci U S A</title>
</titleInfo>
<part>
<date>1995</date>
<detail type="volume">
<caption>vol.</caption>
<number>92</number>
</detail>
<extent unit="pages">
<start>9560</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit26">
<titleInfo>
<title>Nie NH, Hull CH, Jenkins JG et al. Statistical Package for the Social Sciences. New York: McGraw‐Hill, 1975.</title>
</titleInfo>
<note type="citation/reference">Nie NH, Hull CH, Jenkins JG et al. Statistical Package for the Social Sciences. New York: McGraw‐Hill, 1975.</note>
<name type="personal">
<namePart type="given">NH</namePart>
<namePart type="family">Nie</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">CH</namePart>
<namePart type="family">Hull</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">JG</namePart>
<namePart type="family">Jenkins</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book</genre>
<originInfo>
<publisher>McGraw‐Hill</publisher>
</originInfo>
<part>
<date>1975</date>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit27">
<titleInfo>
<title>Glantz SA. Primer of Biostatistics. New York: McGraw‐Hill, 1981.</title>
</titleInfo>
<note type="citation/reference">Glantz SA. Primer of Biostatistics. New York: McGraw‐Hill, 1981.</note>
<name type="personal">
<namePart type="given">SA</namePart>
<namePart type="family">Glantz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book</genre>
<originInfo>
<publisher>McGraw‐Hill</publisher>
</originInfo>
<part>
<date>1981</date>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit28">
<titleInfo>
<title>Nonparametric estimation from incomplete observations</title>
</titleInfo>
<name type="personal">
<namePart type="given">EL</namePart>
<namePart type="family">Kaplan</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P</namePart>
<namePart type="family">Meier</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.</note>
<part>
<date>1958</date>
<detail type="volume">
<caption>vol.</caption>
<number>53</number>
</detail>
<extent unit="pages">
<start>457</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Am Stat Assoc</title>
</titleInfo>
<part>
<date>1958</date>
<detail type="volume">
<caption>vol.</caption>
<number>53</number>
</detail>
<extent unit="pages">
<start>457</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit29">
<titleInfo>
<title>The log‐rank or Mantel–Haenszel test for the comparison of survival curves</title>
</titleInfo>
<name type="personal">
<namePart type="given">DE</namePart>
<namePart type="family">Matthews</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">VT</namePart>
<namePart type="family">Farewell</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host">
<titleInfo>
<title>Using and Understanding Medical Statistics</title>
</titleInfo>
<originInfo>
<publisher>Karger</publisher>
</originInfo>
<part>
<date>1988</date>
<extent unit="pages">
<start>79</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit30">
<titleInfo>
<title>Rat xenograft survival in mice treated with donor‐specific transfusion and anti‐CD154 antibody is enhanced by elimination of host CD4+ cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">EJ</namePart>
<namePart type="family">Gordon</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">BA</namePart>
<namePart type="family">Woda</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LD</namePart>
<namePart type="family">Shultz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gordon EJ, Woda BA, Shultz LD et al. Rat xenograft survival in mice treated with donor‐specific transfusion and anti‐CD154 antibody is enhanced by elimination of host CD4+ cells. Transplantation 2001; 71: 319.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>71</number>
</detail>
<extent unit="pages">
<start>319</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Transplantation</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>71</number>
</detail>
<extent unit="pages">
<start>319</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit31">
<titleInfo>
<title>Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti‐CD154 monoclonal antibody</title>
</titleInfo>
<name type="personal">
<namePart type="given">EJ</namePart>
<namePart type="family">Gordon</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">TG</namePart>
<namePart type="family">Markees</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">NE</namePart>
<namePart type="family">Phillips</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gordon EJ, Markees TG, Phillips NE et al. Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti‐CD154 monoclonal antibody. Diabetes 1998; 47: 1199.</note>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>47</number>
</detail>
<extent unit="pages">
<start>1199</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Diabetes</title>
</titleInfo>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>47</number>
</detail>
<extent unit="pages">
<start>1199</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit32">
<titleInfo>
<title>Blockade of CD40‐mediated signaling is sufficient for inducing islet but not skin transplantation tolerance</title>
</titleInfo>
<name type="personal">
<namePart type="given">NE</namePart>
<namePart type="family">Phillips</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">TG</namePart>
<namePart type="family">Markees</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">JP</namePart>
<namePart type="family">Mordes</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Phillips NE, Markees TG, Mordes JP et al. Blockade of CD40‐mediated signaling is sufficient for inducing islet but not skin transplantation tolerance. J Immunol 2003; 170: 3015.</note>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>170</number>
</detail>
<extent unit="pages">
<start>3015</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Immunol</title>
</titleInfo>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>170</number>
</detail>
<extent unit="pages">
<start>3015</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit33">
<titleInfo>
<title>Mechanisms of transplant tolerance induction using costimulatory blockade</title>
</titleInfo>
<name type="personal">
<namePart type="given">T</namePart>
<namePart type="family">Wekerle</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Kurtz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Bigenzahn</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wekerle T, Kurtz J, Bigenzahn S et al. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 2002; 14: 592.</note>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages">
<start>592</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Curr Opin Immunol</title>
</titleInfo>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>14</number>
</detail>
<extent unit="pages">
<start>592</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit34">
<titleInfo>
<title>Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade</title>
</titleInfo>
<name type="personal">
<namePart type="given">L</namePart>
<namePart type="family">Buhler</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Awwad</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Treter</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Buhler L, Awwad M, Treter S et al. Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade. Transplantation 2002; 73: 12.</note>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>73</number>
</detail>
<extent unit="pages">
<start>12</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Transplantation</title>
</titleInfo>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>73</number>
</detail>
<extent unit="pages">
<start>12</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit35">
<titleInfo>
<title>Xenogeneic transplantation. A review</title>
</titleInfo>
<name type="personal">
<namePart type="given">H</namePart>
<namePart type="family">Auchincloss Jr.</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Auchincloss H Jr. Xenogeneic transplantation. A review. Transplantation 1988; 46: 1.</note>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>46</number>
</detail>
<extent unit="pages">
<start>1</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Transplantation</title>
</titleInfo>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>46</number>
</detail>
<extent unit="pages">
<start>1</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit36">
<titleInfo>
<title>In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneically reconstituted mice (B10+F344 rat—B10)</title>
</titleInfo>
<name type="personal">
<namePart type="given">ST</namePart>
<namePart type="family">Ildstad</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">SM</namePart>
<namePart type="family">Wren</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">SO</namePart>
<namePart type="family">Sharrow</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ildstad ST, Wren SM, Sharrow SO et al. In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneically reconstituted mice (B10+F344 rat—B10). J Exp Med 1984; 160: 1820.</note>
<part>
<date>1984</date>
<detail type="volume">
<caption>vol.</caption>
<number>160</number>
</detail>
<extent unit="pages">
<start>1820</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Exp Med</title>
</titleInfo>
<part>
<date>1984</date>
<detail type="volume">
<caption>vol.</caption>
<number>160</number>
</detail>
<extent unit="pages">
<start>1820</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit37">
<titleInfo>
<title>Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts</title>
</titleInfo>
<name type="personal">
<namePart type="given">ST</namePart>
<namePart type="family">Ildstad</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">DH</namePart>
<namePart type="family">Sachs</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 170.</note>
<part>
<date>1984</date>
<detail type="volume">
<caption>vol.</caption>
<number>307</number>
</detail>
<extent unit="pages">
<start>170</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Nature</title>
</titleInfo>
<part>
<date>1984</date>
<detail type="volume">
<caption>vol.</caption>
<number>307</number>
</detail>
<extent unit="pages">
<start>170</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit38">
<titleInfo>
<title>Mixed allogeneic chimeras prepared by a non‐myeloablative regimen</title>
</titleInfo>
<name type="personal">
<namePart type="given">Y</namePart>
<namePart type="family">Sharabi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">VS</namePart>
<namePart type="family">Abraham</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Sykes</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Sharabi Y, Abraham VS, Sykes M et al. Mixed allogeneic chimeras prepared by a non‐myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant 1992; 9: 191.</note>
<part>
<date>1992</date>
<detail type="volume">
<caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages">
<start>191</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>requirement for chimerism to maintain tolerance</title>
</titleInfo>
<part>
<date>1992</date>
<detail type="volume">
<caption>vol.</caption>
<number>9</number>
</detail>
<extent unit="pages">
<start>191</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit39">
<titleInfo>
<title>Role of intrathymic rat class II+ cells in maintaining deletional tolerance in xenogeneic rat–mouse bone marrow chimeras</title>
</titleInfo>
<name type="personal">
<namePart type="given">B</namePart>
<namePart type="family">Nikolic</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H</namePart>
<namePart type="family">Lei</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">DA</namePart>
<namePart type="family">Pearson</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Nikolic B, Lei H, Pearson DA et al. Role of intrathymic rat class II+ cells in maintaining deletional tolerance in xenogeneic rat–mouse bone marrow chimeras. Transplantation 1998; 65: 1216.</note>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>65</number>
</detail>
<extent unit="pages">
<start>1216</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Transplantation</title>
</titleInfo>
<part>
<date>1998</date>
<detail type="volume">
<caption>vol.</caption>
<number>65</number>
</detail>
<extent unit="pages">
<start>1216</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit40">
<titleInfo>
<title>Tregs and transplantation tolerance</title>
</titleInfo>
<name type="personal">
<namePart type="given">PT</namePart>
<namePart type="family">Walsh</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">DK</namePart>
<namePart type="family">Taylor</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">LA</namePart>
<namePart type="family">Turka</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Walsh PT, Taylor DK, Turka LA. Tregs and transplantation tolerance. J Clin Invest 2004; 114: 1398.</note>
<part>
<date>2004</date>
<detail type="volume">
<caption>vol.</caption>
<number>114</number>
</detail>
<extent unit="pages">
<start>1398</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Clin Invest</title>
</titleInfo>
<part>
<date>2004</date>
<detail type="volume">
<caption>vol.</caption>
<number>114</number>
</detail>
<extent unit="pages">
<start>1398</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit41">
<titleInfo>
<title>Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation‐free protocol</title>
</titleInfo>
<name type="personal">
<namePart type="given">C</namePart>
<namePart type="family">Domenig</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A</namePart>
<namePart type="family">Sanchez‐Fueyo</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Kurtz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Domenig C, Sanchez‐Fueyo A, Kurtz J et al. Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation‐free protocol. J Immunol 2005; 175: 51.</note>
<part>
<date>2005</date>
<detail type="volume">
<caption>vol.</caption>
<number>175</number>
</detail>
<extent unit="pages">
<start>51</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Immunol</title>
</titleInfo>
<part>
<date>2005</date>
<detail type="volume">
<caption>vol.</caption>
<number>175</number>
</detail>
<extent unit="pages">
<start>51</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit42">
<titleInfo>
<title>Treatment of allograft recipients with donor specific transfusion and anti‐CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4‐dependent manner</title>
</titleInfo>
<name type="personal">
<namePart type="given">NN</namePart>
<namePart type="family">Iwakoshi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">JP</namePart>
<namePart type="family">Mordes</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">TG</namePart>
<namePart type="family">Markees</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Iwakoshi NN, Mordes JP, Markees TG et al. Treatment of allograft recipients with donor specific transfusion and anti‐CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4‐dependent manner. J Immunol 2000; 164: 512.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>164</number>
</detail>
<extent unit="pages">
<start>512</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Immunol</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>164</number>
</detail>
<extent unit="pages">
<start>512</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit43">
<titleInfo>
<title>Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft‐vs‐host disease</title>
</titleInfo>
<name type="personal">
<namePart type="given">FH</namePart>
<namePart type="family">Durie</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A</namePart>
<namePart type="family">Aruffo</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Ledbetter</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Durie FH, Aruffo A, Ledbetter J et al. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft‐vs‐host disease. J Clin Invest 1994; 94: 1333.</note>
<part>
<date>1994</date>
<detail type="volume">
<caption>vol.</caption>
<number>94</number>
</detail>
<extent unit="pages">
<start>1333</start>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J Clin Invest</title>
</titleInfo>
<part>
<date>1994</date>
<detail type="volume">
<caption>vol.</caption>
<number>94</number>
</detail>
<extent unit="pages">
<start>1333</start>
</extent>
</part>
</relatedItem>
</relatedItem>
<identifier type="istex">FA45E49EAD425063F681D804106E110FBF006EBC</identifier>
<identifier type="ark">ark:/67375/WNG-MLTTS251-R</identifier>
<identifier type="DOI">10.1111/j.1399-3089.2006.00290.x</identifier>
<identifier type="ArticleID">XEN290</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © Blackwell Munksgaard 2006</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource>
<recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2019-11-16</recordCreationDate>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-MLTTS251-R/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000627 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000627 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:FA45E49EAD425063F681D804106E110FBF006EBC
   |texte=   Anti‐mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021